besides the fact you stole my picture, this is quite a possibility now. Management wouldn’t say NO to an exit chance now, let someone else deal with it type of mentality.
I understand the dump today, given they just did a CR too. However, we all know this is oversold. They still have regulatory approvals elsewhere, they still have sleep apnea, and better yet they can just reapply after the meeting and tweak the approval.
Ann: Update on US FDA De Novo Classification Request, page-68
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #